Human Transmembrane Protease, Serine 2 (TMPRSS-2) Stable Cell Line
|
Catalog Number:
CL-TMPRSS2-001
|
|
|
Price: Please inquire order@eEnzyme.com
Detailed Description
|
CL-TMPRSS2-001
|
|
Name
|
Human Transmembrane Protease, Serine 2 (TMPRSS-2) Stable Cell Line
|
|
Description
|
This HEK293-hTMPRSS2-hACE2 stable cell line expresses a recombinant human Transmembrane Protease, Serine 2 (TMPRSS-2) and a human Angiotensin-Converting Enzyme 2 (ACE2). It can be used for drug screening and for studying SARS-CoV-2 viral entry.
|
|
Characterizations
|
High level expression;
Culture medium: 90%DMEM+10%FBS+1 ug/ml puromycin +250 ug/ml G418
|
|
Size
|
1 mL (frozen cells, 2 x 106 cells before freezing)
|
|
For Downloading
|
==>> DATA SHEET ==>> SAFETY DATA SHEET
|
Synonym: Transmembrane Serine Protease 2, PRSS10, Transmembrane Protease, Serine 2,Transmembrane Protease Serine 2, Serine Protease 10, EC 3.4.21.122, EC 3.4.21.109, Epitheliasin, EC 3.4.21
About Human Transmembrane Serine Protease 2 (TMPRSS2) Stable Cell Line
Transmembrane Serine Protease 2 (TMPRSS2) is a type II transmembrane serine protease expressed in epithelial tissues of the respiratory tract, gastrointestinal tract, and prostate. TMPRSS2 plays an important role in proteolytic processing of cellular and viral proteins and has gained significant attention as a key host factor involved in the entry of several respiratory viruses, including SARS-CoV, SARS-CoV-2, MERS-CoV, and influenza viruses. By cleaving and activating viral fusion proteins, TMPRSS2 facilitates efficient viral entry and infection of host cells. As a result, TMPRSS2 has become an important target for antiviral drug development, host-pathogen interaction studies, and infectious disease research.
Beyond its role in viral infection, TMPRSS2 is also involved in normal epithelial physiology and has been extensively studied in prostate cancer biology. The TMPRSS2 gene is well known for its involvement in TMPRSS2-ERG gene fusions, which are frequently observed in prostate cancer. Consequently, TMPRSS2 has attracted significant interest in oncology, virology, and therapeutic development programs. The ability to modulate TMPRSS2 activity offers potential strategies for preventing viral infection and understanding disease-associated signaling pathways.
eEnzyme's Human TMPRSS2 Stable Cell Line provides a reliable and reproducible cellular platform for studying TMPRSS2 biology and evaluating TMPRSS2-targeted therapeutics. The cell line enables functional assessment of inhibitors, antibodies, biologics, and small molecules that regulate TMPRSS2 activity. Researchers can utilize this cell-based system to investigate viral entry mechanisms, characterize host-pathogen interactions, evaluate compound potency, and support antiviral drug discovery programs. The stable expression system ensures consistent assay performance suitable for routine research and high-throughput screening applications.
Applications of the TMPRSS2 Stable Cell Line
• SARS-CoV-2 and coronavirus entry studies • Influenza virus infection research • Host-pathogen interaction investigations • TMPRSS2 inhibitor screening and characterization • Antiviral drug discovery and development • Antibody and biologic evaluation • Cell signaling and protease biology studies • High-throughput screening applications
Biological Significance of TMPRSS2
TMPRSS2 is a cell-surface serine protease that regulates proteolytic activation of multiple substrates involved in physiological and pathological processes. In respiratory viral infections, TMPRSS2 cleaves viral surface glycoproteins, including coronavirus spike proteins and influenza hemagglutinin, enabling membrane fusion and viral entry into host cells. Inhibition of TMPRSS2 has been shown to reduce viral infectivity, making it an attractive target for host-directed antiviral therapies. In addition, TMPRSS2 has important roles in epithelial biology and prostate cancer, where aberrant TMPRSS2-associated gene fusions contribute to tumor development. Because of its involvement in viral pathogenesis, cancer biology, and protease signaling, TMPRSS2 remains an important target for infectious disease research, oncology studies, and therapeutic development.
|
|
|